STATEMENT - CMA recognizes National Physicians' Day
OTTAWA, ON, May 1, 2024 /CNW/ - On this National Physicians' Day, let me take the opportunity to sincerely thank every Canadian doctor for their hard work and dedication to patient care. Your work and dedication truly matter. You are critical to driving change and transforming our health care systems for the better.
Your every day commitment inspires the CMA to keep trying to make the health care system better for all Canadians. This past year, I've been fortunate to meet doctors from everywhere in the country and I've witnessed your strong desire to improve the way we deliver health and wellness in Canada. As physicians, you experience first-hand the challenges of our health care system and you know which opportunities to seize to make it stronger and accessible for all.
As we've seen in recent developments on physician mobility and health funding, your voice matters and doctors' advocacy truly make a difference. The CMA will continue to elevate your voice, inform health care leaders, and hold decision-makers accountable for real, sustainable change.
Thank you to Canada's physicians for being present with your patients and for speaking up for a healthier future for all.
Dr. Kathleen Ross President, Canadian Medical Association
InteliChart, an award-winning provider of patient engagement solutions for healthcare organizations of all sizes, proudly announced its outstanding performance in the report, InteliChart Patient Portal 2024: Providing a Best-of-Breed Patient Portal...
Ascent Strategy Group, the first public relations agency founded to fuel the digital health revolution, today introduced the industry's first marketing and communications tools created to guide healthcare's transformation. With its mission to advance...
Vantis Vascular, Inc. (Vantis), a pioneering medical technology company founded by physicians with a passion to revolutionize vascular interventions, announced today the successful closing of a $5 million SAFE (Simple Agreement for Future Equity)...
Halozyme Therapeutics, Inc. ("Halozyme") today announced that Bristol Myers Squibb was reassigned a Prescription Drug User Fee Act goal date from the U.S. Food and Drug Administration for their Biologics License Application for the subcutaneous...
OneOncology, the fastest-growing national platform for independent practices, announced that the ASCO Certified Task Force has approved OneOncology Treatment Pathways as appropriate for use in ASCO Certified. OneOncology's 26 unique oncology and...
PureTech Health plc ("PureTech" or the "Company"), a clinical-stage biotherapeutics company, noted today that its Founded Entity, Vedanta Biosciences, a clinical-stage company that is developing a potential new category of oral therapies based on...
